Chris Huang

Title: Chris Huang: Innovator in Therapeutic Polypeptides

Introduction

Chris Huang is a notable inventor based in Paoli, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel polypeptides and antibodies. His work focuses on therapeutic applications that address various diseases.

Latest Patents

Chris Huang holds a patent for CNGH0010, which encompasses specific polynucleotides, polypeptides, antibodies, compositions, methods, and uses. This patent details novel polypeptides (CNGH0010) and antibodies that are specific for at least one such CNGH0010 polypeptide, variant, or fragment. The patent also includes nucleic acids encoding these polypeptides and antibodies, as well as methods for their therapeutic and diagnostic applications. The CNGH0010 polypeptides and antibodies are particularly useful in modulating or treating diseases such as psoriasis, rheumatoid arthritis, and various types of cancer.

Career Highlights

Chris Huang is currently employed at Centocor, Inc., where he continues to advance his research in therapeutic formulations. His innovative work has the potential to impact the treatment of numerous inflammatory and hyperproliferative diseases.

Collaborations

Chris has collaborated with notable colleagues, including Xiao-Yu R Song and Keying Ma, to further enhance the research and development of therapeutic solutions.

Conclusion

Chris Huang's contributions to the field of biotechnology through his patent on CNGH0010 exemplify his commitment to innovation in therapeutic applications. His work not only addresses critical health issues but also paves the way for future advancements in medical treatments.